Percutaneous Coronary Intervention (PCI) Guidelines

Introduction to PCI

The American College of Cardiology/American Heart Association (ACC/AHA) guidelines use the term Percutaneous Coronary Intervention (PCI) to encompass PTCA and other catheter-based techniques, with PTCA specifically referring to balloon angioplasty alone, while PCI includes stenting, atherectomy, and other modern interventional approaches 1, 2, 3

The ACC/AHA guidelines categorize indications using a three-tier system, with Class I indicating evidence and/or general agreement that the procedure is beneficial, useful, and effective 2, 3, 4
The ACC/AHA guidelines define Class IIa as weight of evidence favoring usefulness/efficacy 2, 3
The ACC/AHA guidelines define Class IIb as usefulness/efficacy less well established 2, 3
The ACC/AHA guidelines define Class III as evidence and/or agreement that the procedure is not useful/effective and may be harmful 2, 3

The American College of Cardiology recommends CABG over PCI for multivessel CAD with diabetes mellitus, particularly when left internal mammary artery graft can be anastomosed to the LAD 5
The American College of Cardiology recommends CABG for complex 3-vessel CAD with or without proximal LAD involvement in good surgical candidates 5
The American College of Cardiology suggests PCI is reasonable for triple vessel disease with severe angina when patients have favorable anatomy with high likelihood of success and low procedural risk 5

The American College of Cardiology recommends CABG after failed PTCA in the presence of ongoing ischemia or threatened occlusion with significant myocardium at risk 6
The American College of Cardiology recommends emergency CABG for most patients with acute MI who have persistent angina or hemodynamic instability following failed PTCA 7

The American College of Cardiology guidelines are intended for operators who possess the cognitive and technical skills for performing PCI and assume that facilities and resources required to properly perform PCI are available 1, 2, 3

The American College of Cardiology guidelines incorporate significant advances in adjunctive medical therapies, including glycoprotein IIb/IIIa receptor antagonists 3
The American College of Cardiology guidelines incorporate significant advances in adjunctive medical therapies, including bivalirudin 3
The American College of Cardiology guidelines incorporate significant advances in adjunctive medical therapies, including thienopyridines 3
The American College of Cardiology guidelines incorporate significant advances in adjunctive medical therapies, including drug-eluting stents (DES) 2, 3, 8

PTA (Percutaneous Transluminal Angioplasty), also called PTCA (Percutaneous Transluminal Coronary Angioplasty), is a balloon‑based catheter technique that dilates narrowed coronary arteries and serves as the foundational procedure from which modern Percutaneous Coronary Intervention (PCI) evolved. [9][10]
PTCA refers specifically to balloon angioplasty alone, whereas contemporary ACC/AHA guidelines use the term PCI to encompass the full spectrum of catheter‑based coronary therapies. [9][10]

When selecting PTCA, clinicians should weigh the risk/benefit ratio against coronary bypass surgery; factors linked to higher mortality with PTCA include: female sex, age > 65 years, congestive heart failure, unstable angina, left‑main coronary disease, three‑vessel disease, and left ventricular ejection fraction < 30 %. [11][12]

PCI is defined as a catheter‑based procedure that includes balloon angioplasty, intracoronary stenting, and other percutaneous techniques (e.g., atherectomy, thrombectomy, laser angioplasty) to relieve coronary artery narrowing and restore myocardial blood flow. 13, 14, 15
The ACC/AHA guidelines formally adopted the term “PCI” to reflect the evolution beyond simple balloon dilation to include stenting and atheroablative technologies. 13, 14

Standard balloon angioplasty (PTCA) remains the foundational technique for dilating narrowed coronary arteries. 13, 15
Intracoronary stent implantation is performed in approximately 80–85 % of PCI procedures in the United States and markedly reduces acute vessel closure and restenosis compared with balloon‑only techniques. 14, 15
Drug‑eluting stents (DES) significantly lower the risk of restenosis relative to bare‑metal stents. 13, 14, 15
Atheroablative technologies (rotational, directional, extraction atherectomy, and laser angioplasty) are available as adjunctive options for heavily calcified or resistant lesions. 13, 14
Thrombectomy devices may be employed in selected lesion subsets, although definitive clinical outcome benefits have not been firmly established. 14, 15

PCI start time is defined as the moment local anesthetic is first administered for vascular access, or the time of the first vascular access attempt—whichever occurs earlier. 16
Any attempt to treat a coronary stenosis—whether successful or not (e.g., failed wire crossing)—is counted as a PCI procedure. 16

PCI provides greater angina relief than sham (placebo) procedures in patients with stable angina and documented ischemia who are on minimal anti‑anginal therapy. 17

Primary PCI is the recommended reperfusion strategy for ST‑elevation myocardial infarction (STEMI), with a target door‑to‑balloon time of ≤90 minutes. 18
An early invasive strategy that includes PCI improves outcomes in high‑risk unstable angina or non‑ST‑elevation myocardial infarction (NSTEMI) patients who exhibit recurrent ischemia, dynamic ST changes, elevated cardiac biomarkers, or hemodynamic instability. 19

Glycoprotein IIb/IIIa receptor antagonists reduce procedure‑related myocardial infarction rates from roughly 10 % to 5 %. 20, 14
Dual antiplatelet therapy with thienopyridines (e.g., clopidogrel, prasugrel, ticagrelor) is essential for preventing stent thrombosis. 13, 14
Bivalirudin is an alternative anticoagulant option during PCI. 13

Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) offer superior vessel and plaque characterization compared with angiography alone, facilitating optimal lesion preparation, stent sizing, and deployment. 21
Despite proven benefits, intravascular imaging is employed in fewer than 15 % of PCI procedures, indicating a notable practice gap. 21

Balloon angioplasty historically resulted in acute vessel closure in about 5 % of cases and restenosis rates of 35–45 % at six months; these complications have been dramatically reduced by routine stent implantation. 15

Significant left‑main coronary artery disease (≥50 % stenosis) in patients eligible for coronary artery bypass grafting (CABG) is considered a contraindication to PCI. 19